The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia
Open accessAbstract
BACKGROUND: Evidence supports an independent association between plasma total homocysteine concentrations and the risk of vascular disease. Recent epidemiologic studies reappraised the possibility that vascular risk factors might play a role in the pathogenesis not only of vascular dementia (VaD) but also of Alzheimer disease (AD). OBJECTIVE: The objective was to investigate the relations of mild cognitive impairment, AD, and VaD with blood homocysteine, folate, and vitamin B-12. DESIGN: The study population consisted of 314 consecutive subjects, 228 of whom were eligible for analyses. Plasma total homocysteine, serum folate, and serum vitamin B-12 concentrations were measured in 55 nondemented elderly control subjects, 81 mildly cognitively impaired subjects (Clinical Dementia Rating: 0.5), and 92 demented patients prevalently in a mild disease stage and with a clinical diagnosis of AD (n = 74) or VaD (n = 18). RESULTS: Subjects in the lowest folate tertile had significantly higher adjusted odds ratios (ORs) for mild cognitive impairment (OR: 3.1; 95% CI: 1.2, 8.1) and dementia (3.8; 1.3, 11.2). Hyperhomocysteinemia was significantly associated with dementia (adjusted OR: 4.3; 1.3, 14.7) and AD (adjusted OR: 3.7; 1.1, 13.1). In subjects with a Clinical Dementia Rating of 0.5, the mean (+/- SE) Mini-Mental State Examination score was significantly lower (P < 0.05) in the highest homocysteine tertile (24.5 +/- 0.5) than in the lowest tertile (26.6 +/- 0.5). No significant associations were found between minimum medial temporal lobe thickness or leukoaraiosis and any biochemical measure in the dementia and AD groups. CONCLUSIONS: These findings suggest that relative folate deficiency may precede AD and VaD onset. Hyperhomocysteinemia might also be an early risk factor for cognitive decline in the elderly, but its role in dementia development must be addressed in future longitudinal studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972 · cited 1×
“However, an inadequate dietary intake of nutritional factors such as B-vitamins has a major effect on homocysteinemia: some 65% of the hyperhomocysteinemia cases among the Framingham elderly population-based cohort could be accounted for by inadequate folate, or, to a lesser extent, inadequate vitamin B-12 or vitamin…”
BackgroundHomocysteine and cardiovascular disease: evidence on causality from a meta-analysis
Wald, D. S., Law, M., & Morris, J. K. (2002) · BMJ · doi:10.1136/bmj.325.7374.1202 · Cited by 1,946
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,851
Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.
Ks, M. (1969) · PubMed Central · Cited by 1,803
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Methionine metabolism in mammals
Finkelstein, J. D. (1990) · The Journal of Nutritional Biochemistry · doi:10.1016/0955-2863(90)90070-2 · Cited by 1,491
Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease
Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., & Ueland, P. M. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1449 · Cited by 1,408
The Clinical Diagnosis of Alzheimer's Disease
Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130016010 · Cited by 1,374
Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
Collaboration, H. L. T. (1998) · BMJ · doi:10.1136/bmj.316.7135.894 · Cited by 1,084
Hofman, A., Ott, A., Breteler, M. M., Bots, M. L., Slooter, A. J., van Harskamp, F., van Duijn, C. N., Van Broeckhoven, C., & Grobbee, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09328-2 · Cited by 1,062
Homocysteine and vascular disease
Hankey, G. J., & Eikelboom, J. W. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11058-9 · Cited by 1,052
Neurotoxicity associated with dual actions of homocysteine at the N -methyl- d -aspartate receptor
Lipton, S. A., Kim, W.-K., Choi, Y.-B., Kumar, S., D’Emilia, D. M., Rayudu, P. V., Arnelle, D. R., & Stamler, J. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5923 · Cited by 847
Kruman, I. I., Culmsee, C., Chan, S. L., Kruman, Y., Guo, Z., Penix, L., & Mattson, M. P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06920.2000 · Cited by 784
Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study
Vermeer, S. E., den Heijer, T., Koudstaal, P. J., Oudkerk, M., Hofman, A., & Breteler, M. M. B. (2003) · Stroke · doi:10.1161/01.str.0000052631.98405.15 · Cited by 680
Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550020046024 · Cited by 674
Vascular risk factors for Alzheimer’s disease:
Breteler, M. M. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00110-4 · Cited by 664
Kruman, I. I., Kumaravel, T. S., Lohani, A., Pedersen, W. A., Cutler, R. G., Kruman, Y., Haughey, N., Lee, J., Evans, M., & Mattson, M. P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01752.2002 · Cited by 643
The controversy over homocysteine and cardiovascular risk
Ueland, P. M., Refsum, H., Beresford, S. A., & Vollset, S. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.324 · Cited by 517
Riggs, K., Spiro, A., Tucker, K., & Rush, D. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.3.306 · Cited by 509
Homocysteine and cardiovascular disease: cause or effect?
Brattström, L., & Wilcken, D. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.315 · Cited by 439
Duan, W., Ladenheim, B., Cutler, R. G., Kruman, I. I., Cadet, J. L., & Mattson, M. P. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00676.x · Cited by 405
Total serum homocysteine in senile dementia of Alzheimer type
McCaddon, A., Davies, G., Hudson, P., Tandy, S., & Cattell, H. (1998) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199804)13:4<235::aid-gps761>3.0.co;2-8 · Cited by 398
Holmes, C., Cairns, N., Lantos, P. L., & Mann, A. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.174.1.45 · Cited by 359
Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam scan study
Vermeer, S. E., Van Dijk, E. J., Koudstaal, P. J., Oudkerk, M., Hofman, A., Clarke, R., & Breteler, M. M. B. (2002) · Annals of Neurology · doi:10.1002/ana.10111 · Cited by 355
Brain Infarction and the Clinical Expression of Alzheimer Disease
Roman, G. C. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550020045023 · Cited by 350
Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias
Moroney, J. T., Bagiella, E., Desmond, D. W., Hachinski, V. C., Mölsä, P. K., Gustafson, L., Brun, A., Fischer, P., Erkinjuntti, T., Rosen, W., et al. (1997) · Neurology · doi:10.1212/wnl.49.4.1096 · Cited by 316
Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual?
Christen, W. G., Ajani, U. A., Glynn, R. J., & Hennekens, C. H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.422 · Cited by 304
Homocysteine and brain atrophy on MRI of non-demented elderly
den Heijer, T., Vermeer, S. E., Clarke, R., Oudkerk, M., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2003) · Brain · doi:10.1093/brain/awg006 · Cited by 282
Snowdon, D. A., Tully, C. L., Smith, C. D., Riley, K. P., & Markesbery, W. R. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.4.993 · Cited by 276
Smith, A. D., Jobst, K. A., Szatmari, M., Jaskowski, A., King, E., Smith, A., Molyneux, A., Esiri, M. E., McDonald, B., & Wald, N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92890-r · Cited by 259
Identification of Cognitive Impairment in the Elderly: Homocysteine Is an Early Marker
Lehmann, M., Gottfries, C. G., & Regland, B. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017092 · Cited by 245
Homocysteine, B vitamin status, and cognitive function in the elderly
Duthie, S. J., Whalley, L. J., Collins, A. R., Leaper, S., Berger, K., & Deary, I. J. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.5.908 · Cited by 244
Homocysteine, white matter hyperintensities, and cognition in healthy elderly people
Dufouil, C., Alpérovitch, A., Ducros, V., & Tzourio, C. (2003) · Annals of Neurology · doi:10.1002/ana.10440 · Cited by 241
Kalmijn, S., Launer, L. J., Lindemans, J., Bots, M. L., Hofman, A., & Breteler, M. M. B. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010000 · Cited by 237
McIlroy, S. P., Dynan, K. B., Lawson, J. T., Patterson, C. C., & Passmore, A. P. (2002) · Stroke · doi:10.1161/01.str.0000032550.90046.38 · Cited by 227
Diagnostic evaluation of degenerative and vascular dementia.
Loeb, C., & Gandolfo, C. (1983) · Stroke · doi:10.1161/01.str.14.3.399 · Cited by 222
Joosten, E., Lesaffre, E., Riezler, R., Ghekiere, V., Dereymaeker, L., Pelemans, W., & Dejaeger, E. (1997) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/52a.2.m76 · Cited by 187
Homocysteine, vitamin B 6 , and vascular disease in AD patients
Miller, J. W., Green, R., Mungas, D. M., Reed, B. R., & Jagust, W. J. (2002) · Neurology · doi:10.1212/wnl.58.10.1471 · Cited by 164
Hyperhomocysteinaemia—a common finding in a psychogeriatric population
Nilsson, K. H., Gustafson, L., Fäldt, R., Andersson, A. D. R., Brattström, L. E., Lindgren, A. G., Israelsson, B., & Hultberg, B. L. (1996) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1996.tb02129.x · Cited by 163
Elevated Plasma Homocysteine Levels and Risk of Silent Brain Infarction in Elderly People
Matsui, T., Arai, H., Yuzuriha, T., Yao, H., Miura, M., Hashimoto, S., Higuchi, S., Matsushita, S., Morikawa, M., Kato, A., et al. (2001) · Stroke · doi:10.1161/01.str.32.5.1116 · Cited by 162
Hogervorst, E., Ribeiro, H. M., Molyneux, A., Budge, M., & Smith, A. D. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.787 · Cited by 159
An alternative view of homocysteine
Dudman, N. P. B. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03383-8 · Cited by 155
Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals
Sachdev, P. S., Valenzuela, M., Wang, X. L., Looi, J. C., & Brodaty, H. (2002) · Neurology · doi:10.1212/wnl.58.10.1539 · Cited by 144
Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals
Bleich, S., & Kornhuber, J. (2003) · Neurology · doi:10.1212/wnl.60.7.1220 · Cited by 137
Crystal, H., Ortof, E., Frishman, W. H., Gruber, A., Hershman, D. L., & Aronson, M. K. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06583.x · Cited by 116
Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people
Williams, J. H., Pereira, E. A. C., Budge, M. M., & Bradley, K. M. (2002) · Age and Ageing · doi:10.1093/ageing/31.6.440 · Cited by 95
Abnormal amino acid metabolism in patients with early stage Alzheimer dementia
Fekkes, D., van der Cammen, T. J. M., van Loon, C. P. M., Verschoor, C. J., van Harskamp, F., de Koning, I., Schudel, W. J., & Pepplinkhuizen, L. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050058 · Cited by 84
Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment
Ravaglia, G., Forti, P., Maioli, F., Vettori, C., Grossi, G., Bargossi, A., Caldarera, M., Franceschi, C., Facchini, A., Mariani, E., et al. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00221-9 · Cited by 80
Clarke, R., Lewington, S., Donald, A., Johnston, C., Refsum, H., STRATTON, I. M., Jacques, P. F., Breteler, M. M. B., & Holman, R. R. (2001) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670100800605 · Cited by 69
A Pilot Study of Vitamins to Lower Plasma Homocysteine Levels in Alzheimer Disease
Aisen, P. S. S., Egelko, S., Andrews, H., Diaz-Arrastia, R. R., Weiner, M., DeCarli, C. S., Jagust, W., Miller, J. W., Green, R., Bell, K. L., et al. (2003) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200303000-00016 · Cited by 67
Cobalamin Levels Are Not Reduced in Alzheimer's Disease: Results from a Population‐Based Study
Basun, H., Fratiglioni, L., & Winblad, B. G. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb04939.x · Cited by 64
Homocysteine and cardiovascular risk
Scott, J. M. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.333 · Cited by 63
Alzheimer's disease and brain infarcts in the elderly
Zekry, D., Duyckaerts, C. J., Belmin, J., Geoffre, C., Moulias, R., & Hauw, J. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0883-1 · Cited by 51
The C677T Mutation in the Methylenetetrahydrofolate Reductase (MTHFR) Gene and Vascular Dementia
Pollak, R. D., Pollak, A., Idelson, M., Bejarano‐Achache, I., Doron, D., & Blumenfeld, A. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04725.x · Cited by 51
Clinical assessment of Alzheimer's disease
Morris, J. C. (1997) · Neurology · doi:10.1212/wnl.49.3_suppl_3.s7 · Cited by 41
Clarke, R., Joachim, C. L., Esiri, M. M., Morris, J. R., Bungay, H. K., Molyneux, A., Budge, M. M., Frost, C. D., KING, E., Barnetson, L. P. D., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06405.x · Cited by 19
Cited by
Vitamin B12, folic acid, and the nervous system
Reynolds, E. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70598-1 · Cited by 860
Age-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease
Wang, S.-C., Oelze, B., & Schumacher, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002698 · Cited by 466
Metal dyshomeostasis and oxidative stress in Alzheimer’s disease
Greenough, M. A., Camakaris, J., & Bush, A. I. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.014 · Cited by 436
Homocysteine and folate as risk factors for dementia and Alzheimer disease
Ravaglia, G., Forti, P., Maioli, F., Martelli, M., Servadei, L., Brunetti, N., Porcellini, E., & Licastro, F. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.3.636 · Cited by 500
Alzheimer’s disease and gut microbiota
Hu, X., Wang, T., & Jin, F. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-5083-9 · Cited by 371
Metadata
- Authors
- Quadri, P., Fragiacomo, C., Pezzati, R., Zanda, E., Forloni, G., Tettamanti, M., & Lucca, U.
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2004-07
- Volume
- 80
- Issue
- 1
- Pages
- 114-122
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2116950438
- Cited by
- 339
- References
- 63
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.